Dela Cruz, Rena .

HRN: 28-56-90  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/22/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
02/22/2026
02/23/2026
IV
500 Mg
Q8
Sp 1 LTCS
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines